Recent reports that major institutions have expanded positions in Waystar Holding (WAY), alongside strong year over year revenue and net profit growth, have put the stock in focus for investors watching healthcare software exposure.

Despite the recent institutional interest, Waystar Holding’s 30 day share price return is down 5.8% and its year to date share price return is down 41.1%, while the 1 year total shareholder return has fallen 51.4%. This points to fading momentum as investors reassess growth expectations and risk after the strong revenue and profit updates.

If you are comparing Waystar Holding with other healthcare technology names, it can help to broaden your watchlist using a focused screener. One option is to scan for specialist healthcare AI opportunities via the 41 healthcare AI stocks.

With Waystar Holding trading at $18.47, alongside an implied intrinsic discount of 55.4% and a sizable gap to the average analyst price target, the key question is whether this weakness signals mispricing or whether the market already reflects future growth.

Most Popular Narrative: 45.4% Undervalued

With Waystar Holding shares at $18.47 against a narrative fair value of $33.83, the current discount frames a very different long term earnings story.

The acquisition of Iodine Software, a leading provider of AI-powered clinical intelligence, will expand Waystar's total addressable market by over 15%, accelerate its product roadmap, and immediately boost gross margins and adjusted EBITDA margins, setting up compounding, long-term revenue and earnings growth.

Want to see what sits behind that confidence in Waystar Holding? Revenue compounding, margin expansion, and a premium future earnings multiple all sit at the heart of this narrative.

Result: Fair Value of $33.83 (UNDERVALUED)

However, there are still clear watchpoints for the Waystar Holding narrative, including higher leverage after the Iodine deal and potential pricing pressure from larger healthcare provider customers.

Next Steps

Given the mixed sentiment around Waystar Holding, it makes sense to move quickly, review the underlying data, and shape your own view. To see what investors are optimistic about right now, take a closer look at the 4 key rewards.

Looking for more investment ideas beyond Waystar Holding?

If Waystar Holding has sharpened your focus on quality, do not stop here. Keep building a watchlist so you are ready when opportunities line up.

• Zero in on potential value opportunities by screening for companies trading below what their fundamentals suggest through the 45 high quality undervalued stocks.
• Strengthen your focus on capital preservation by checking out the 66 resilient stocks with low risk scores and seeing which stocks score well on stability and risk controls.
• Expand your watchlist with under followed opportunities by using the screener containing 20 high quality undiscovered gems and spotting companies with solid fundamentals that many investors may be overlooking.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.